Eli Lilly (LLY) Stock Price, Quote, News & History | Benzinga

Eli Lilly and Co (LLY) Stock Price, Quote, News & History

LLYNYSE

Trade with Public

Trade with Public

$1180.16

-28.84-2.39%

At close: Aug 14, 5:00 PM EST

Dividend: The dividend Ex-Date was 2 days ago

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$1.19K

Close

$1.18K

Volume / Avg.

2.27M / 2.99M

Day Range

$1.17K - $1.20K

52 Wk Range

644.50 - 1.25K

Market Cap

$1.05T

P/E Ratio

40.58

Dividend Yield

0.57%

Exchange

NYSE

RSI

50

Short Interest

1.02%

Days to Cover

3.94

Recent Eli Lilly and Company News

Russell 2000 Extends Records, SanDisk Rallies 7%: Stock Market Today

Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, while crude climbed and SanDisk extended its post-Investor Day run.

Piero Cingari

Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’

Vinod Khosla says AI is revolutionizing drug discovery, but drug testing needs to catch up with more human-relevant methods.

Snigdha Gairola

Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to Authorities

Eli Lilly filed six lawsuits against U.S. entities for illegally selling unapproved retatrutide, warning consumers of serious health risks.

Vandana Singh

Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lilly to acquire AtaiBeckley for $3.8B.

Avi Kapoor

Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients

Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new federal program.

Namrata Sen

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.08B

Investing Cash Flow (TTM)

-25.10B

Financing Cash Flow (TTM)

2.61B

Free Cash Flow (TTM)

13.56B

Capital Expenditure (TTM)

-14.52B

Net Change in Cash (TTM)

5.59B

Analyst Trends and Forecast

3

Apr

5

May

2

Jun

10

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.10T

PE Ratio (TTM)

40.58

PE Ratio (FWD)

33.33

PEG Ratio (TTM)

1.52

PS Ratio (TTM)

13.61

PB Ratio (TTM)

31.81

Earnings Yield % (TTM)

2.46%

Earnings Yield % (FWD)

3.00%

EV / EBITDA (TTM)

26.94

Price / EBITDA (TTM)

25.99

Price / Free Cash Flow (TTM)

79.94

Book Value / Share

$38.01

Company Debt

Total Debt

$54.91B

LT Debt

$47.86B

LT Debt Issuance (TTM)

$15.65B

LT Debt Repayment (TTM)

-$1.62B

Total Cash

$8.95B

Debt to Equity

1.62

Issuance of Debt (TTM)

$14.02B

Repayment of Debt (TTM)

-$1.62B

Key Statistics

Open

$1.19K

Close

$1.18K

Volume / Avg.

2.27M / 2.99M

Day Range

$1.17K - $1.20K

52 Wk Range

644.50 - 1.25K

Market Cap

$1.05T

P/E Ratio

40.58

Dividend Yield

0.57%

Exchange

NYSE

RSI

50

Short Interest

1.02%

Days to Cover

3.94

About

Sector

Health Care

Industry

Pharmaceuticals

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometaboli...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Eli Lilly (LLY) stock?

A

You can purchase shares of Eli Lilly (NYSE:LLY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Eli Lilly (LLY) competitors?

A

Other companies in Eli Lilly’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

Q

What is the forecast, or price target, for Eli Lilly (LLY) stock?

A

Eli Lilly has a consensus price target of $1237.45.

Q

What is the current price for Eli Lilly (LLY)?

A

The stock price for Eli Lilly (NYSE: LLY) is $1180 last updated August 14, 2026 at 7:59 PM EDT.

Q

Does Eli Lilly (LLY) pay a dividend?

A

There are no upcoming dividends for Eli Lilly.

Q

When is Eli Lilly (NYSE:LLY) reporting earnings?

A

Eli Lilly does not have any upcoming earnings scheduled.

Q

Is Eli Lilly (LLY) going to split?

A

There is no upcoming split for Eli Lilly.

Q

What sector and industry does Eli Lilly (LLY) operate in?

A

Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.